Group structure
3 companies in 2 countries
Singapore1
Headquarters not stated1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
1–25 of 184
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABENOL120 mg · Suppository | Paracetamol | Canada | Not marketed | 1992 |
| ABENOL325 mg · Suppository | Paracetamol | Canada | Not marketed | 1992 |
| ABENOL650 mg · Suppository | Paracetamol | Canada | Not marketed | 1992 |
| ACET 120120 mg · Suppository | Paracetamol | Canada | Marketed | 1998 |
| ACET 160160 mg · Suppository | Paracetamol | Canada | Marketed | 1998 |
| ACET 325325 mg · Suppository | Paracetamol | Canada | Marketed | 1998 |
| ACET 650650 mg · Suppository | Paracetamol | Canada | Marketed | 1998 |
| ACID REDUCER150 mg · Tablet | Ranitidine | Canada | Authorised | |
| ANTI-ALLERGY EYE DROPS2 % · Solution | Cromolyn | Canada | Authorised | |
| ARTIFICIAL TEARS FOR DRY EYES1.4 % · Solution | Polyvinyl alcohol | Canada | Not marketed | 1997 |
| AXID150 mg · Capsule | Nizatidine | Canada | Marketed | 1988 |
| AXID300 mg · Capsule | Nizatidine | Canada | Not marketed | 1988 |
| BACITIN500 unit / g · Ointment | Bacitracin | Canada | Marketed | 1984 |
| BI-PEGLYTE5 mg / tab + 59.55 g / sachet + 0.76 g / sachet + 1.69 g / sachet + 1.46 g / sachet + 5.74 g / sachet · Kit, Powder For Solution, Tablet (Delayed-Release) | Bisacodyl, Macrogol, Potassium chloride, Bicarbonate, Sodium chloride, Sodium sulfate | Canada | Marketed | 2010 |
| COLYTE857.69 mg / g + 10.65 mg / g + 24.02 mg / g + 20.87 mg / g + 81.2 mg / g · Powder For Solution | Macrogol, Potassium chloride, Bicarbonate, Sodium chloride, Sodium sulfate | Canada | Marketed | 1986 |
| CROMOLYN EYE DROPS2 % · Solution | Cromolyn | Canada | Marketed | 1993 |
| DEMYLOCAN50 mg / vial · Powder | Decitabine | Canada | Marketed | 2021 |
| ENTERIC COATED A.S.A650 mg · Tablet (Delayed-Release) | Acetylsalicylic acid | Canada | Not marketed | 2005 |
| ENTERIC COATED A.S.A325 mg · Tablet (Delayed-Release) | Acetylsalicylic acid | Canada | Not marketed | 2005 |
| ENTERIC COATED A.S.A.650 mg · Tablet (Delayed-Release) | Acetylsalicylic acid | Canada | Authorised | |
| ENTERIC COATED A.S.A (CAPLET)325 mg · Tablet (Delayed-Release) | Acetylsalicylic acid | Canada | Authorised | |
| ENTERIC COATED ASA 325 MG325 mg · Tablet (Delayed-Release) | Acetylsalicylic acid | Canada | Not marketed | 2007 |
| ENTROPHEN81 mg · Tablet (Delayed-Release) | Acetylsalicylic acid | Canada | Marketed | 2000 |
| ENTROPHEN 325MG CAPLETS325 mg · Tablet (Delayed-Release) | Acetylsalicylic acid | Canada | Not marketed | 1993 |
| ENTROPHEN 325MG TABLETS325 mg · Tablet (Delayed-Release) | Acetylsalicylic acid | Canada | Not marketed | 1951 |